No picture, placeholder image
No picture, placeholder image
Institutt for klinisk medisin egil.blix@uit.no

Egil Støre Blix


Førsteamanuensis


  • Oleksii Nikolaienko, Hans Petter Eikesdal, Elisabet Ognedal Berge, Bjørnar Gilje, Steinar Lundgren, Egil Støre Blix m.fl.:
    Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
    Genome Medicine 2023 ARKIV / DOI
  • Synnøve Yndestad, Christina Engebrethsen, A. Herencia-Ropero, Oleksii Nikolaienko, Olav Karsten Vintermyr, Reidun Kristine Lillestøl m.fl.:
    Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer
    JCO Precision Oncology (JCO PO) 2023 ARKIV / DOI
  • Jürgen Geisler, Peeter Karihtala, Malgorzata Tuxen, Antonis Valachis, Cecilia Ahlin, Cathrine Bergquist Fosskaug m.fl.:
    Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study
    Acta Oncologica 15. september 2023 FULLTEKST / ARKIV / DOI
  • Albulena Mecinaj, Geeta Gulati, Siri Lagethon Heck, Espen Holte, Morten Wang Fagerland, Alf Inge Larsen m.fl.:
    Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial
    Cardio-Oncology 27. september 2021 ARKIV / DOI
  • Hans Petter Eikesdal, Synnøve Yndestad, Asmaa Elzawahry, Alba Llop-Guevara, Bjørnar Gilje, Egil Støre Blix m.fl.:
    Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
    Annals of Oncology 24. november 2020 ARKIV / DOI
  • Thomas Helland, Bjørn Naume, Steinar Hustad, Ersilia Bifulco, Jan Terje Kvaløy, Anna Barbro Sætersdal m.fl.:
    Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
    Molecular Oncology 2020 ARKIV / DOI
  • Lars Ottestad, Line Fronth, Sajitha Rajendiran, Liv Hege Aksnes, Hans Petter Eikesdal, Egil Støre Blix m.fl.:
    Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer
    Acta Oncologica 2019 DOI
  • Sigurd Hald, Mehrdad Rakaee, Inigo Zubiavrre Martinez, Elin Richardsen, Samer Al-Saad, Erna Elise Paulsen m.fl.:
    LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
    Clinical Lung Cancer 2018 DOI
  • Giulio Francolini, Mette S. Thomsen, Esben S. Yates, Carine Kirkove, Ingelise Jensen, Egil Støre Blix m.fl.:
    Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1
    Radiotherapy and Oncology 2017 DOI
  • Ahmed R. Eldesoky, Giulio Francolini, Mette S. Thomsen, Esben S. Yates, Tine B. Nyeng, Carine Kirkove m.fl.:
    Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study
    Clinical and Translational Radiation Oncology 2017 DOI
  • Kari Flo, Egil Støre Blix, Anne Husebekk, Anders Thommassen, Andreas Tendeland Uhre, Tom Wilsgaard m.fl.:
    A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy
    Acta Obstetricia et Gynecologica Scandinavica 2016 DOI
  • Egil Støre Blix, Anne Husebekk :
    Raiders of the lost mark – endothelial cells and their role in transplantation for hematologic malignancies
    Leukemia and Lymphoma 2016 DOI
  • AR Eldesoky, ES Yates, TB Nyeng, MS Thomsen, HM Nielsen, P Poortmans m.fl.:
    Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
    Radiotherapy and Oncology 2016 DOI
  • Egil Støre Blix, Anders Benjamin Kildal, Eirin Listau Bertelsen, Anders Waage, June Myklebust, Arne Kolstad m.fl.:
    Content of endothelial progenitor cells in autologous stem cellgrafts predict survival after transplantation for multiplemyeloma
    Biology of Blood and Marrow Transplantation 2015 ARKIV / DOI
  • Egil Støre Blix, Jonathan M. Irish, Anne Husebekk, Jan Delabie, Lise Forfang, Anne Tierens m.fl.:
    Phospho-spesific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
    BMC Cancer 2012 ARKIV / DOI
  • Camilla Øvrebø ONDRČKOVA, Åslaug Helland, Egil Støre Blix, Daniel Heinrich, Kristina Yvonne Kathe Lindemann :
    ESMO-kongressen 2023 – dette gleder kreftlegene seg til
    20. oktober 2023
  • Egil Støre Blix :
    Åslaug Helland og Egil Blix, • IMPRESS–Norway - hvordan går det?
    2022
  • Egil Støre Blix :
    A national precision cancer medicine implementation initiative for Norway
    Nature Medicine 2022 DOI
  • Åslaug Helland, Hege Elisabeth Giercksky Russnes, Gro Live Fagereng, Khalid Ibrahim Al-Shibli, Yvonne Andersson, Thomas Berg m.fl.:
    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5)
    Journal of Translational Medicine 2022 DOI
  • Åslaug Helland, Hege Elisabeth Giercksky Russnes, Gro Live Fagereng, Khalid Ibrahim Al-Shibli, Yvonne Andersson, Thomas Berg m.fl.:
    Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    Journal of Translational Medicine 14. mai 2022 ARKIV / FULLTEKST / DOI
  • Hans Petter Eikesdal, Synnøve Yndestad, Egil Støre Blix, Steinar Lundgren, Geirfinn Vagstad, Helge Espelid m.fl.:
    Neoadjuvant olaparib monotherapy in primary triple negative breast cancer
    2019
  • Hans Petter Eikesdal, Christina Clausen, Egil Støre Blix, Steinar Lundgren, Geirfinn Vagstad, Helge Espelid m.fl.:
    Neoadjuvant endocrine therapy with palbociclib in patients with high-risk breast cancer
    2019
  • Egil Støre Blix :
    Persontilpasset medisin hos pasienter med brystkreft
    2019
  • Mona Stedenfeldt, Pål Øian, Mika Gissler, Egil Støre Blix, Jouko Pirhonen :
    Authors' reply: Risk factors for obstetric anal sphincter injury after a successful multicentre interventional programme
    BJOG: An International Journal of Obstetrics and Gynaecology 2014 DOI
  • Kari Flo, Anne Husebekk, Åse VÅrtun, Egil Støre Blix, Tom Wilsgaard, Ganesh Acharya :
    A longitudinal study of maternal vascular reactivity, circulating endothelial progenitor celss and inflammatory response during the second half of pregnancy
    Pregnancy Hypertension 2013
  • Mona Stedenfeldt, Jouko Pirhonen, Egil Støre Blix, Tom Wilsgaard, Barthold Vonen, Pål Øian :
    Epsiotomy characterisitics and risk for anal sphincter injuries: a case-control study
    Acta Obstetricia et Gynecologica Scandinavica 2012
  • Mona Stedenfeldt, Jouko Pirhonen, Egil Støre Blix, Tom Wilsgaard, Barthold Vonen, Pål Øian :
    ANAL INCONTINENCE AND SEXUAL PROBLEMS IN WOMEN WITH EPISIOTOMY - A MATCHED CASE-CONTROL STUDY
    Neurourology and Urodynamics 2012
  • Egil Støre Blix, Jonathan M. Irish, Anne Husebekk, Jan Delabie, Anne Tierens, June Myklebust m.fl.:
    Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
    British Journal of Haematology 2012 DOI
  • Egil Støre Blix, Anne Husebekk :
    Endothelial progenitor cells (EPC)-expression and function in cancer
    2006
  • Egil Støre Blix, Anne Husebekk :
    Endothelial progenitor cells (EPC)- expression and function in cancer
    Regional forskningskonferanse innen medisin og helse 2006

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →